A. Krishen

发表

Optimally weighted, fixed sequence and gatekeeper multiple testing procedures

P. Westfall, A. Krishen, 2001 .

Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES

N. Benowitz, R. West, A. Krishen, 2018, Addiction.

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

R. Muirhead, J. Maca, A. Dmitrienko, 2007 .

Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double‐blind, placebo‐controlled study

P. Anand, A. Krishen, R. Lai, 2013, European journal of pain.

Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.

A. Rush, J. Modell, J. Jefferson, 2006, The Journal of clinical psychiatry.

Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium.

A. Krishen, M. Diamond, V. Martin, 2014, Journal of women's health.

Cardiovascular adverse events in the drug‐development program of bupropion for smoking cessation: A systematic retrospective adjudication effort

V. Hasselblad, S. Russell, K. Mahaffey, 2017, Clinical cardiology.

NSAIDs and cognition in Alzheimer's disease

A. Metz, P. Doraiswamy, A. Krishen, 1996, Neurology.

Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion.

N. Richard, J. Modell, A. Krishen, 2010, Primary care companion to the Journal of clinical psychiatry.

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

V. Milanova, J. Modell, A. Krishen, 2009, Journal of psychopharmacology.

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled study

B. Jamerson, A. Metz, A. Krishen, 2001, Clinical pharmacology and therapeutics.

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder

A. Krishen, M. Gee, W. Chrzanowski, 2010, Journal of psychopharmacology.

A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy

P. Anand, A. Krishen, R. Lai, 2015, The Clinical journal of pain.

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

N. Benowitz, R. West, A. Krishen, 2016, The Lancet.

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

N. Benowitz, R. West, A. Krishen, 2019, Journal of General Internal Medicine.

Seasonal Affective Disorder and Its Prevention by Anticipatory Treatment with Bupropion XL

A. Metz, J. Modell, A. Krishen, 2005, Biological Psychiatry.

Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial

N. Benowitz, R. West, A. Krishen, 2019, Journal of clinical psychopharmacology.

Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.

R. West, A. Krishen, D. Lawrence, 2019, Journal of affective disorders.

Resolution of Sleepiness and Fatigue in Major Depressive Disorder: A Comparison of Bupropion and the Selective Serotonin Reuptake Inhibitors

M. Fava, D. Nutt, A. Krishen, 2006, Biological Psychiatry.

Sumatriptan‐Naproxen and Butalbital: A Double‐Blind, Placebo‐Controlled Crossover Study

S. Silberstein, R. Cady, A. Krishen, 2012, Headache.

Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study.

K. Chang, M. DelBello, A. Krishen, 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

N. Richard, J. Modell, A. Krishen, 2006, The Journal of clinical psychiatry.

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.

M. Fava, S. Stahl, A. Krishen, 2008, The Journal of clinical psychiatry.

Sudden unexpected death in epilepsy in lamotrigine randomized‐controlled trials

R. Leadbetter, D. Friedman, T. Tomson, 2013, Epilepsia.

Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors

N. Benowitz, R. West, A. Krishen, 2021, Addiction.

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

J. Modell, A. Krishen, G. Evoniuk, 2010, Journal of psychopharmacology.

A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Sustained-Release Bupropion on Blood Pressure in Individuals With Mild Untreated Hypertension

B. Haight, M. Thase, J. Modell, 2008, Journal of clinical psychopharmacology.

Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender–age interactions

S. Kornstein, A. Krishen, C. Soares, 2007, International clinical psychopharmacology.

Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials.

M. Thase, S. Montgomery, A. Krishen, 2007, The Journal of clinical psychiatry.

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials.

M. Trivedi, J. Alpert, A. Krishen, 2008, Journal of psychiatric research.

Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.

K. Krishnan, B. Jamerson, J. Modell, 2003, Psychopharmacology bulletin.

Cognitive performance on the Alzheimer's Disease Assessment Scale

A. Metz, P. Doraiswamy, A. Krishen, 1995, Neurology.